SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001047469-10-008963
Filing Date
2010-10-28
Accepted
2010-10-28 16:53:45
Documents
10
Period of Report
2010-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a2200597z10-q.htm 10-Q 752851
2 EX-31.1 a2200597zex-31_1.htm EX-31.1 7761
3 EX-31.2 a2200597zex-31_2.htm EX-31.2 7776
4 EX-32.1 a2200597zex-32_1.htm EX-32.1 4405
  Complete submission text file 0001047469-10-008963.txt   7166836

Data Files

Seq Description Document Type Size
5 EX-101.INS vrtx-20100930.xml EX-101.INS 807985
6 EX-101.SCH vrtx-20100930.xsd EX-101.SCH 76746
7 EX-101.CAL vrtx-20100930_cal.xml EX-101.CAL 62690
8 EX-101.LAB vrtx-20100930_lab.xml EX-101.LAB 848660
9 EX-101.PRE vrtx-20100930_pre.xml EX-101.PRE 361153
10 EX-101.DEF vrtx-20100930_def.xml EX-101.DEF 251379
Mailing Address
Business Address 130 WAVERLY STREET CAMBRIDGE MA 02139-4242 6165776000
VERTEX PHARMACEUTICALS INC / MA (Filer) CIK: 0000875320 (see all company filings)

IRS No.: 043039129 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19319 | Film No.: 101148756
SIC: 2834 Pharmaceutical Preparations